These results suggest that elevated expression of MCP-4 in ovarian cancer tissues is associated with poor prognosis and that high expression of MCP-4 may serve as an independent risk factor for predicting the prognosis of patients with ovarian cancer. The gene discussed is CCL13; the disease is ovarian carcinoma.